Expertise in
2
conditions

Hidemasa Oh

Okayama, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Okayama, JP 

Overview

Hidemasa Oh practices practicing medicine in Okayama, Japan.

Oh is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Hypoplastic Left Heart Syndrome (HLHS), Congenital Heart Disease (CHD), Dilated Cardiomyopathy (DCM), and Heart Failure.

They are actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 2 clinical trials.

Locations

Okayama, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease: A Multicenter Randomized Single-blind Parallel-group Study
Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease: A Multicenter Randomized Single-blind Parallel-group Study
Enrollment Status: Recruiting
Publish Date: September 30, 2025
Intervention Type: Genetic
Study Phase: Phase 3
A Prospective Phase 1 Trial of Cardiac Progenitor Cell Therapy in Children With Dilated Cardiomyopathy
A Prospective Phase 1 Trial of Cardiac Progenitor Cell Therapy in Children With Dilated Cardiomyopathy
Enrollment Status: Completed
Publish Date: November 26, 2021
Intervention Type: Biological
Study Drug: CDC infusion
Study Phase: Phase 1
View 1 Less Clinical Trial

11 Total Publications

Eight-Year Outcomes of Cardiosphere-Derived Cells in Single Ventricle Congenital Heart Disease.
Eight-Year Outcomes of Cardiosphere-Derived Cells in Single Ventricle Congenital Heart Disease.
Journal: Journal of the American Heart Association
Published: November 11, 2024

Frequently Asked Questions about Hidemasa Oh

Is Hidemasa Oh a top-rated expert for Hypoplastic Left Heart Syndrome (HLHS)?

MediFind is an objective health platform that identifies experts based on real-world data. Hidemasa Oh is classified as an Elite expert for Hypoplastic Left Heart Syndrome (HLHS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hidemasa Oh participate in research or clinical trials?

Yes. Hidemasa Oh has published 11 articles and abstracts on conditions like Hypoplastic Left Heart Syndrome (HLHS). You can view a list of Hidemasa Oh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Oh's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile